Morphologic and functional changes in nontumorous liver tissue after radiofrequency ablation in an in vivo model: Comparison of18F-FDG PET/CT, MRI, ultrasound, and CT

Journal of Nuclear Medicine

Volumn 48, Issue 11, 2007, Pages 1836-1844

  Vogt, Florian M ^a   Antoch, Gerald ^a   Veit, Patrick ^a   Freudenberg, Lutz S ^a   Blechschmid, Nina ^a   Diersch, Olaf ^b   Bockisch, Andreas ^a   Barkhausen, Jörg ^a   Kuehl, Hilmar ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Minimally invasive technique; Periablational region; Peripheral enhancement; Tissue necrosis; Tissue response

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC IMAGING; FOLLOW UP; IN VIVO STUDY; INTERMETHOD COMPARISON; LIVER; LIVER FUNCTION; LIVER PARENCHYMA; LIVER TUMOR; MINIMALLY INVASIVE SURGERY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; RADIOFREQUENCY ABLATION; SWINE; TISSUE NECROSIS; TISSUE REGENERATION; ULTRASOUND;

ANIMALS; CATHETER ABLATION; FLUORODEOXYGLUCOSE F18; LIVER; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; NECROSIS; NEOPLASM, RESIDUAL; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; SWINE; SWINE, MINIATURE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 36049047732     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.107.042846     Document Type: Article

References (34)

1. Solbiati L, Livraghi T, Goldberg SN, et al. Percutaneous radio-frequency ablation of hepatic metastases from colorectal cancer: long-term results in 117 patients. Radiology. 2001;221:159-166.
2. McGhana JP, Dodd GD III. Radiofrequency ablation of the liver: current status. AJR. 2001;176:3-16.
3. Solbiati L, Goldberg SN, Ierace T, et al. Hepatic metastases: percutaneous radiofrequency ablation with cooled-tip electrodes. Radiology. 1997;205:367-373.
4. Rossi S, Buscarini E, Garbagnati F, et al. Percutaneous treatment of small hepatic tumors by an expandable RF needle electrode. AJR. 1998;170:1015-1022.
5. Dupuy DE, Goldberg SN. Image-guided radiofrequency tumor ablation: challenges and opportunities - part II. J Vasc Interv Radiol. 2001;12:1135-1148.
6. Kuvshinoff BW, Ota DM. Radiofrequency ablation of liver tumors: influence of technique and tumor size. Surgery. 2002;132:605-611.
7. Wood TF, Rose DM, Chung M, Allegra DP, Foshag LJ, Bilchik AJ. Radiofrequency ablation of 231 unresectable hepatic tumors: indications, limitations, and complications. Ann Surg Oncol. 2000;7:593-600.
8. Solbiati L, Ierace T, Tonolini M, Osti V, Cova L. Radiofrequency thermal ablation of hepatic metastases. Eur J Ultrasound. 2001;13:149-158.
9. Ng KK, Lam CM, Poon RT, et al. Porcine liver: morphologic characteristics and cell viability at experimental radiofrequency ablation with internally cooled electrodes. Radiology. 2005;235:478-486.
10. Goldberg SN, Gazelle GS, Compton CC, Mueller PR, Tanabe KK. Treatment of intrahepatic malignancy with radiofrequency ablation: radiologic-pathologic correlation. Cancer. 2000;88:2452-2463.
11. Goldberg SN, Charboneau JW, Dodd GD III, et al. Image-guided tumor ablation: proposal for standardization of terms and reporting criteria. Radiology. 2003;228:335-345.
12. Choi H, Loyer EM, DuBrow RA, et al. Radio-frequency ablation of liver tumors: assessment of therapeutic response and complications. Radiographics. 2001;21:S41-S54.
13. Kim TJ, Moon WK, Cha JH, et al. VX2 carcinoma in rabbits after radiofrequency ablation: comparison of MR contrast agents for help in differentiating benign periablational enhancement from residual tumor. Radiology. 2005;234:423-430.
14. Anderson GS, Brinkmann F, Soulen MC, Alavi A, Zhuang H. FDG positron emission tomography in the surveillance of hepatic tumors treated with radiofrequency ablation. Clin Nucl Med. 2003;28:192-197.
15. Langenhoff BS, Oyen WJ, Jager GJ, et al. Efficacy of fluorine-18- deoxyglucose positron emission tomography in detecting tumor recurrence after local ablative therapy for liver metastases: a prospective study. J Clin Oncol. 2002;20:4453-4458.
16. 18F-FDG PET/CT. J Nucl Med. 2004;45(suppl 1):56S-65S.
17. Kruskal JB, Oliver B, Huertas JC, Goldberg SN. Dynamic intrahepatic flow and cellular alterations during radiofrequency ablation of liver tissue in mice. J Vasc Interv Radiol. 2001;12:1193-1201.
18. Lazebnik RS, Breen MS, Fitzmaurice M, Nour SG, Lewin JS, Wilson DL. Radio-frequency-induced thermal lesions: subacute magnetic resonance appearance and histological correlation. J Magn Reson Imaging. 2003;18:487-495.
19. Antoch G, Vogt FM, Veit P, et al. Assessment of liver tissue after radiofrequency ablation: findings with different imaging procedures. J Nucl Med. 2005;46:520-525.
20. Lencioni R, Goletti O, Armillotta N, et al. Radio-frequency thermal ablation of liver metastases with a cooled-tip electrode needle: results of a pilot clinical trial. Eur Radiol. 1998;8:1205-1211.
21. Kinahan PE, Townsend DW, Beyer T, Sashin D. Attenuation correction for a combined 3D PET/CT scanner. Med Phys. 1998;25:2046-2053.
22. Cioni D, Lencioni R, Bartolozzi C. Percutaneous ablation of liver malignancies: imaging evaluation of treatment response. Eur J Ultrasound. 2001;13:73-93.
23. Dromain C, de Baere T, Elias D, et al. Hepatic tumors treated with percutaneous radio-frequency ablation: CT and MR imaging follow-up. Radiology. 2002;223:255-262.
24. Tacke J. Percutaneous radiofrequency ablation: clinical indications and results [in German]. RöFo. 2003;175:156-168.
25. Lencioni R, Cioni D, Crocetti L, et al. Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation. Radiology. 2005;234:961-967.
26. Yan FH, Shen JZ, Li RC, et al. Enhancement patterns of small hepatocellular carcinoma shown by dynamic MRI and CT. Hepatobiliary Pancreat Dis Int. 2002;1:420-424.
27. Bipat S, van Leeuwen MS, Comans EF, et al. Colorectal liver metastases: CT, MR imaging, and PET for diagnosis - meta-analysis. Radiology. 2005;237:123-131.
28. Sironi S, Livraghi T, Meloni F, De Cobelli F, Ferrero C, Del Maschio A. Small hepatocellular carcinoma treated with percutaneous RF ablation: MR imaging follow-up. AJR. 1999;173:1225-1229.
29. Tanimoto A, Kuwatsuru R, Kadoya M, et al. Evaluation of gadobenate dimeglumine in hepatocellular carcinoma: results from phase II and phase III clinical trials in Japan. J Magn Reson Imaging. 1999;10:450-460.
30. Harisinghani MG, Jhaveri KS, Weissleder R, et al. MRI contrast agents for evaluating focal hepatic lesions. Clin Radiol. 2001;56:714-725.
31. Bluemke DA, Sahani D, Amendola M, et al. Efficacy and safety of MR imaging with liver-specific contrast agent: U.S. multicenter phase III study. Radiology. 2005;237:89-98.
32. Puls R, Kroncke TJ, Kluner C, et al. Double contrast MRI of thermally ablated liver metastases [in German]. RöFo. 2003;175:1467-1470.
33. Paul SB, Gulati MS. Spectrum of hepatocellular carcinoma on triple phase helical CT: a pictorial essay. Clin Imaging. 2002;26:270-279.
34. Veit P, Antoch G, Stergar H, Bockisch A, Forsting M, Kuehl H. Detection of residual tumor after radiofrequency ablation of liver metastasis with dual-modality PET/CT: initial results. Eur Radiol. 2006;16:80-87.